What is iRhythm Technologies?
Founded in 2006, iRhythm Technologies specializes in the manufacturing of advanced medical devices and digital health platforms. The company's core offering involves proprietary wearable biosensors integrated with cloud-based data analytics, designed for the detection, prediction, and prevention of cardiac conditions. By processing vast amounts of cardiac data, iRhythm's algorithms transform raw information into actionable clinical insights for healthcare providers. Operating globally across North America, Europe, and the Asia-Pacific region, the company serves both business-to-business and business-to-consumer markets through its sophisticated digital ecosystem.
How much funding has iRhythm Technologies raised?
iRhythm Technologies has raised a total of $337.2M across 10 funding rounds:
Other Financing Round
$10M
Series C
$22M
Private Equity
$12.2M
Debt
$3.5M
Series D
$16M
Series E
$17M
Stock Offering
$123M
Stock Offering
$115M
Other Financing Round (2010): $10M supported by Mohr Davidow Ventures, Synergy Life Science Partners, and St. Jude Medical
Series C (2011): $22M featuring Synergy Life Science Partner, Kaiser Permanente Ventures, Mohr Davidow Ventures, St. Jude Medical, New Leaf Venture Partners, and Stanford University
Private Equity (2012): $12.2M backed by New Leaf Venture Partners, Mohr Davidow Ventures, Kaiser Permanente Ventures, and Synergy Life Science Partner
Debt (2012): $3.5M, investors not publicly disclosed
Series D (2013): $16M led by Norwest Venture Partners, New Leaf Venture Partners, Kaiser Permanente Ventures, and Synergy Life Science Partners
Series E (2014): $17M supported by Norwest Venture Partners and Novo A/S
Stock Issuance/Offering (2016): $123.1M, investors not publicly disclosed
Stock Issuance/Offering (2019): $115M, investors not publicly disclosed
Key Investors in iRhythm Technologies
New Leaf Venture Partners
New Leaf Venture Partners is a venture capital firm dedicated to corporate technology spinouts, providing a bridge between technology corporations and traditional venture capital. They offer a systematic process for commercializing innovations and have a strong track record in early-stage investments.
Kaiser Permanente Ventures
Kaiser Permanente Ventures is a national leader in strategic venture investing in healthcare, focusing on advancing healthcare innovation. They partner with entrepreneurs to build promising healthcare solutions that provide clear value for patients and providers.
Mohr Davidow Ventures
Mohr Davidow Ventures specializes in innovative tools aimed at enhancing productivity and streamlining processes, supporting entrepreneurs who recognize significant market opportunities and are driven to pursue them.
What's next for iRhythm Technologies?
With a history of consistent capital infusion, iRhythm Technologies is well-positioned for its next phase of expansion. The recent funding, coupled with its substantial total investment to date, will likely fuel further research and development into next-generation diagnostic tools and data analytics capabilities. Strategic initiatives may include expanding its global footprint, enhancing its product portfolio to address a wider range of chronic diseases, and forging deeper partnerships within the healthcare industry to integrate its solutions more seamlessly into clinical workflows. The company's focus on preventative care and data-driven insights aligns with the growing demand for efficient and effective healthcare solutions.
See full iRhythm Technologies company page
